Tibet Duo Rui Pharmaceutical Co., Ltd.

301075

CNE100004RW5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-29 EDT			5-day change	1st Jan Change
18.3 ^CNY	-1.51%		-1.98%	-31.38%

05-07	Tranche Update on Tibet Duo Rui Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 5, 2024.	CI
04-30	Tibet Duo Rui Pharmaceutical Co., Ltd.'s Equity Buyback announced on February 5, 2024, has closed with 1,044,500 shares, representing 1.31% for CNY 20.98 million.	CI

Tibet Duo Rui Pharmaceutical Co.,Ltd. agreed to acquire 51% stake in Hongxi Medical Technology Co., Ltd. for CNY 0.

January 16, 2024

Tibet Duo Rui Pharmaceutical Co.,Ltd. (SZSE:301075) agreed to acquire 51% stake in Hongxi Medical Technology (Tianjin) Co., Ltd. from Li Zhanbing, Tian Bin, Zhang Hengrui and Xiong Rongliang for CNY 0 on January 17, 2024. As of October 31, 2023, Hongxi Medical Technology (Tianjin) Co., Ltd. generated total assets of CNY 0.28 million and net assets of

Latest news about Tibet Duo Rui Pharmaceutical Co., Ltd.

Tranche Update on Tibet Duo Rui Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 5, 2024.	05-07	CI
Tibet Duo Rui Pharmaceutical Co., Ltd.'s Equity Buyback announced on February 5, 2024, has closed with 1,044,500 shares, representing 1.31% for CNY 20.98 million.	04-29	CI
Tibet Duo Rui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
Tibet Duo Rui Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-17	CI
Shiyan Jiaruihe Traditional Chinese Medicine Co., Ltd announced that it expects to receive CNY 7 million in funding from Tibet Duo Rui Pharmaceutical Co., Ltd., Shiyan Shenqi Agricultural Development Co., Ltd.	04-11	CI
Tranche Update on Tibet Duo Rui Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 5, 2024.	04-01	CI
Tibet Duo Rui Pharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 30 million worth of its shares.	02-05	CI
Tibet Duo Rui Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.	02-04	CI
Jiangxi Kelun Pharmaceutical Co., Ltd. and Hubei Yinuokang Medical Technology Co., Ltd. agreed to acquire 49% stake in Wuhan Quanruinuo Pharmaceutical Technology Co., Ltd. from Tibet Duo Rui Pharmaceutical Co.,Ltd. for CNY 0.	01-18	CI
Tibet Duo Rui Pharmaceutical Co.,Ltd. agreed to acquire 51% stake in Hongxi Medical Technology Co., Ltd. for CNY 0.	01-16	CI
Tibet Duo Rui Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Tibet Duo Rui Pharmaceutical Co.,Ltd. completed the acquisition of 38.125% stake in Hubei Xinchengda Chemical Co., Ltd. from Wuhan Shengxiang Chemical Co., Ltd. and Wuhan Jinshengxing Automatic Control Engineering Co., Ltd.	23-09-19	CI
Tibet Duo Rui Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Tibet Duo Rui Pharmaceutical Co.,Ltd. entered into a Investment Intent Agreement to acquire 38.125% stake in Hubei Xinchengda Chemical Co., Ltd. from Wuhan Shengxiang Chemical Co., Ltd. and Wuhan Jinshengxing Automatic Control Engineering Co., Ltd. for CNY 30.5 million.	23-08-03	CI
Tibet Duo Rui Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24	CI
Tibet Duo Rui Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-24	CI
Tibet Duo Rui Pharmaceutical Co.,Ltd. Announces Directorate Appointments	23-03-07	CI
Hubei Tianji Pharmaceutical Co., Ltd. announced that it expects to receive CNY 60 million in funding from Tibet Duo Rui Pharmaceutical Co.,Ltd.	22-11-13	CI
Tibet Duo Rui Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-24	CI
Langhao Medical Technology Co., Ltd. announced that it has received CNY 4 million in funding from Tibet Duo Rui Pharmaceutical Co.,Ltd.	22-09-29	CI
Tibet Duo Rui Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI

Chart Tibet Duo Rui Pharmaceutical Co., Ltd.

Duration

Period

Chart Tibet Duo Rui Pharmaceutical Co., Ltd.

More charts

Company Profile

Tibet Duo Rui Pharmaceutical Co Ltd is a company mainly engaged in the research and development (R&D), production and sales of chemical preparations and their active pharmaceutical ingredients (APIs). The Company's core product is sodium acetate ringer injection, which is mainly used to supplement body fluid, regulate electrolyte balance and correct acidosis. The Company's products also include its own products, compound electrolyte injection, compound mannitol injection and cefotaxime sodium for injection.

Sector

Pharmaceuticals

Calendar

2024-08-22 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
TIBET DUO RUI PHARMACEUTICAL CO., LTD.	-31.38%	200M
ELI LILLY AND COMPANY	+39.82%	734B
NOVO NORDISK A/S	+31.34%	591B
JOHNSON & JOHNSON	-7.31%	350B
MERCK & CO., INC.	+14.23%	315B
ABBVIE INC.	+0.86%	276B
ASTRAZENECA PLC	+13.47%	238B
ROCHE HOLDING AG	-6.63%	204B
NOVARTIS AG	+7.49%	206B
AMGEN INC.	+4.51%	161B